Showing results (931-940 of 5,690) with videos related to

Sort By:
Pageof 569
The Oncologist|February 20, 2020
Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade TherapyAmir H Ameri, Ruth K Foreman, Priyanka Vedak, et al.
The Oncologist|July 21, 2021
Acceptability, Utility, and Cost of a Mobile Health Cancer Screening Education Application for Training Primary Care Physicians in IndiaSujha Subramanian, Regi Jose, Anoop Lal, et al.
The Oncologist|July 21, 2021
Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European CenterMarija Ivanović, Lea Knez, Ana Herzog, et al.
The Oncologist|July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid TumorsKhanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
The Oncologist|July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction AdenocarcinomaDaniel V Catenacci, Joseph Chao, Kei Muro, et al.
The Oncologist|May 23, 2022
Time to Mammographic Density Decrease After Exposure to TamoxifenMagnus Bäcklund, Mikael Eriksson, Mattias Hammarström, et al.
The Oncologist|May 13, 2022
Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative DataJacques Raphael, Lucie Richard, Melody Lam, et al.
The Oncologist|May 19, 2022
Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related ComplicationsCindy Y Jiang, Lili Zhao, Scott M Schuetze, et al.
The Oncologist|May 19, 2022
Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control StudyRobert Lam, Nicholas Tarangelo, Rong Wang, et al.
The Oncologist|December 10, 2022
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast CancerEric M Lander, Katherine C Rappazzo, Li-Ching Huang, et al.
Pageof 569